Etidronic acid
Clinical data | |
---|---|
[[Regulation of therapeutic goods |Template:Engvar data]] | |
Pregnancy category |
|
Routes of administration | Oral, intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 3% |
Metabolism | Nil |
Elimination half-life | 1 to 6 hours |
Excretion | Renal and fecal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C2H8O7P2 |
Molar mass | 206.028 g/mol |
WikiDoc Resources for Etidronic acid |
Articles |
---|
Most recent articles on Etidronic acid Most cited articles on Etidronic acid |
Media |
Powerpoint slides on Etidronic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Etidronic acid at Clinical Trials.gov Trial results on Etidronic acid Clinical Trials on Etidronic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Etidronic acid NICE Guidance on Etidronic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Etidronic acid Discussion groups on Etidronic acid Patient Handouts on Etidronic acid Directions to Hospitals Treating Etidronic acid Risk calculators and risk factors for Etidronic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Etidronic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Etidronic acid (INN) or etidronate disodium (trade name Didronel®) is a bisphosphonate used to strengthen bone, treat osteoporosis, and treat Paget's disease of bone.
Chelating Agent and Anti-oxidant
Etidronic acid is a chelating agent and may be added to bind or, to some extent, counter the effects of substances, such as arsenic, iron, or other metal ions (that can occur in the presence of some soaps), which may be discharged as a component of grey wastewater and could conceivably contaminate groundwater supplies. Etidronic acid also acts to retard rancidification and oxidation of fatty acids. While etidronic acid has not been limited from inclusion in cosmetics and does have legitimate uses, it is recommended that, as with most cosmetic products (particularly soaps), the product should be thoroughly rinsed from the skin after use.
Etidronic acid is listed as an ingredient of several cosmetic formulations. Several examples of Etidronic acid's presence in soap products are: Propolis soap, Dove body wash, Axe body wash, Lever 2000 body wash, Yardley of London, Johnson and Johnson's Lavender, Chamomile Creamy Baby Soap bar and Tesco Pure Soap bar.
Etidronic acid is also included among swimming pool chemicals. It is used as a stain inhibitor to prevent metal ions coming out of solution and staining the sides of swimming pools.
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Bisphosphonates
- Endocrinology